
About Aspect Biosystems
Aspect Biosystems is a Technology company based in Vancouver (Canada) founded in 2013 by Simon Beyer, Tamer Mohamed, Sam Wadsworth, and Konrad Walus. Bioprinting technology and tissue therapeutics for regenerative medicine are developed. Aspect Biosystems has raised $138.68 million across 5 funding rounds from investors including Novo Nordisk, Innovate BC and Canadian Space Agency. Its chief executive, as recorded, is Tamer Mohamed. Its website aspectbiosystems.com draws about 18 thousand monthly visits. Aspect Biosystems offers products and services including Bioprinting Technology Platform. Its focus areas include High Tech, 3D Printing, Hardware and 3D Printers. Its legal entity is ASPECT BIOSYSTEMS LTD.
Company details
Aspect Biosystems was founded in 2013 in Vancouver, Canada. Bioprinting technology and tissue therapeutics are developed within the regenerative medicine sector. The platform is integrated with computational design, therapeutic cells, and biomaterials to produce implantable tissues. These tissues are designed to replace, repair, or supplement biological functions, particularly for metabolic and endocrine diseases. Collaborations with other organizations are maintained to advance operations.
- Headquarters Vancouver, Canada
- Founders Simon Beyer, Tamer Mohamed, Sam Wadsworth, Konrad Walus
- SectorsTechnology
- Website aspectbiosystems.com
- Social LinkedIn X YouTube
- Legal Name Aspect Biosystems Ltd.
- Total Equity Funding$138.68M (USD)
in 5 rounds
- Latest Funding Round$115M (USD), Series B
Jan 2025
- InvestorsNovo Nordisk
& 11 more
Products & Services of Aspect Biosystems
Aspect Biosystems offers a comprehensive portfolio of products and services, including Bioprinting Technology Platform.
AI-powered system for creating implantable tissues to treat diseases.
Apps and channels of Aspect Biosystems
its YouTube channel Aspect Biosystems has 647 subscribers and 2 videos.
Videos from Aspect Biosystems
The most watched videos on Aspect Biosystems's YouTube channel, Aspect Biosystems (647 subscribers). Click a video to play it here.
More on Aspect Biosystems.
Funding Insights of Aspect Biosystems
Aspect Biosystems has successfully raised a total of $138.68M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $115 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $138.68M
- Total Rounds 5
- Last Round Series B β $115M
- Investors Count 12
All 5 funding rounds of Aspect Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $115M | Series B | β | Dimension | |
| Jan 2020 | $19.98M | Series A | β | Radical Ventures | |
| Nov 2018 | $2.7M | Series A | β | β | |
| May 2018 | $1M | Series A | β | β | |
| Sep 2017 | Series A | β | Pangaea Ventures |
12 investors in total: 12 institutional.
Investors in Aspect Biosystems
Aspect Biosystems has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Novo Nordisk, Innovate BC and Canadian Space Agency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dimension is focused on investments at the intersection of technology and life sciences. | dimensioncap.com | |||
Early-stage sector agnostic VC firm investing primarily in the US and Canada | pallasiteventures.com | Vancouver, Canada | ||
Companies developing T1D products are funded through venture philanthropy. | t1dfund.org | Boston, United States | ||
Startup accelerator firm backed by the British Columbia Government | 2004 | innovatebc.ca | Vancouver, Canada | |
Early-stage venture capital funding is provided by Rhino Ventures. | rhinovc.com | Vancouver, Canada | ||
Venture capital firm focused on AI-driven companies | radical.vc | Toronto, Canada | ||
Investment in hard tech for planetary health, focusing on materials science, chemistry, and biology. | pangaeaventures.com | |||
Early-stage investments are made in tech and offline companies. | endurecap.com | Palo Alto, United States | ||
Relentless Venture Fund is focused on health technology investments. | relentlesspursuitpartners.com | Vancouver, Canada | ||
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured. | 1923 | novonordisk.com | Bagsvaerd, Denmark |
Investor details for Aspect Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aspect Biosystems
65 people are tracked at Aspect Biosystems (12 in leadership, 12 in board & advisors, 41 in team).
| Name | Role | Group |
|---|---|---|
Simon Beyer | Co-Founder & CTO | Leadership |
Tamer Mohamed | Co-Founder & CEO | Leadership |
Sam Wadsworth | Co-Founder & CSO | Leadership |
Konrad Walus | Co-Founder | Leadership |
Nicole Swanson | Executive Assistant To Chief Executive Officer | Leadership |
Natalie Korenic | Chief Of Staff To The CEO & Sr. Director, Communications | Leadership |
Lin-P'Ing Choo-Smith | Director, Preclinical Programs | Leadership |
Ray Smith | CFO | Leadership |
Amanda Fox | Director, Talent | Leadership |
Lloyd MacKenzie | Chief Technical Operations Officer | Leadership |
Claire Cahill | Director, Contracts | Leadership |
Reza Jalili | Director, In Vivo Sciences | Leadership |
Don Haut | Board Member | Board & advisors |
Andrew Booth | Advisor | Board & advisors |
Kamran Alam | Advisor | Board & advisors |
Anil Dhawan | Scientific Advisor | Board & advisors |
Andrew Haughian | Board Member | Board & advisors |
Salim Teja | Board Member | Board & advisors |
James Shapiro | Scientific Advisor | Board & advisors |
Jane Lebkowski | Scientific Advisor | Board & advisors |
45 more people are available in the full profile.
Complete people profiles for Aspect Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aspect Biosystems
3 dated milestones of Aspect Biosystems across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Aspect Biosystems is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $115.0M.
Web traffic of Aspect Biosystems
The website of Aspect Biosystems (aspectbiosystems.com) receives about 17.8K visits a month.
- Monthly visits17.8K
▲ 166.8% vs previous month
Websites whose visitors overlap most with Aspect Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abcellera.com | 100% | 29.9K | #868,912 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aspect Biosystems
Complete news archive for Aspect Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aspect Biosystems
Aspect Biosystems was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Aspect Biosystems is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Tamer Mohamed is the CEO of Aspect Biosystems, as recorded in our data. They have also founded this company.
Aspect Biosystems is a funded company, having raised a total of $138.68M across 5 funding rounds to date.
Aspect Biosystems was founded in 2013 in Vancouver, Canada. Bioprinting technology and tissue therapeutics are developed within the regenerative medicine sector. The platform is integrated with computational design, therapeutic cells, and biomaterials to produce implantable tissues. These tissues are designed to replace, repair, or supplement biological functions, particularly for metabolic and endocrine diseases. Collaborations with other organizations are maintained to advance operations.
Aspect Biosystems offers Bioprinting Technology Platform.
Aspect Biosystems has 12 investors. Key investors include Novo Nordisk, Innovate BC, Canadian Space Agency, Dimension, and Pallasite Ventures.
Aspect Biosystems operates through Aspect Biosystems Ltd..
